Shares of Moderna MRNA have surged 33.5% over the past week, adding nearly $8 billion to the company's market value. The ...

The study also reviews the great potential of mRNA vaccines to treat influenza, RSV, cancer, and autoimmune diseases.

Messenger RNA (mRNA) vaccines are one of the biggest medical breakthroughs of recent years. It was first introduced during ...

The technology that gave the world mRNA COVID vaccines is being tested in a variety of new ways, and emerging research ...

The mRNA vaccines approved to treat COVID-19 are safe and effective and show promise in treating other diseases including ...

A first-of-its-kind flu shot is one step closer to being available to the public after a Food and Drug Administration (FDA) ...

A comprehensive new review published in The Lancet affirms that currently approved mRNA vaccines are safe and highly ...

At Science Day, Moderna outlined growth plans across infectious-disease vaccines, Intismeran, and rare-disease therapeutics. ...

A comprehensive review of the billions of COVID-19 vaccine doses made with mRNA technology shows that these vaccines are safe and effective. Vaccine skepticism increased during the COVID-19 pandemic, ...

CHICAGO, June 9 (Reuters) - Treatments based on the same mRNA technology that delivered COVID-19 vaccines to market in record time are showing lasting benefit against the deadly skin cancer melanoma ...

Investor interest has focused on companies nearing key milestones, signing major partnerships, or improving their business ...

Moderna Inc. Chief Executive Officer Stephane Bancel said he sees the pending launch of a planned flu vaccine as a chance to ...